DEF 14A: Nuwellis Seeks Stockholder Approval for Reverse Stock Split, Executive Compensation, and Warrant Provisions
Proxy Statement
Nuwellis, Inc. is holding its 2024 annual meeting of stockholders to vote on key proposals including a reverse stock split to maintain Nasdaq listing, executive compensation, and approval of anti-dilution provisions in common warrants.
Summary
- Nuwellis, Inc. is soliciting proxies for its 2024 annual meeting of stockholders to be held virtually on June 6, 2024.
- Key proposals include the election of two Class II directors, a reverse stock split at a ratio between 1-for-5 and 1-for-70, advisory votes on executive compensation and its frequency, ratification of Baker Tilly US, LLP as the independent auditor, approval of anti-dilution provisions in common warrants, and authorization to adjourn the meeting if necessary.
- The Board recommends voting for all director nominees and for Proposals 2, 3, 5, 6, and 7, and for every three years for Proposal 4.
- The reverse stock split aims to regain compliance with Nasdaq's minimum bid price requirement.
- If approved, the reverse stock split will reduce the number of outstanding shares but not affect stockholders' percentage ownership, except for fractional shares which will be paid out in cash.
- The company is also seeking approval for anti-dilution provisions in common warrants issued in a recent offering, which could lead to further dilution if exercised.
- Executive compensation includes base salaries, equity compensation, and non-equity incentive plan compensation, with recent measures to reduce cash burn rate including salary reductions and suspension of 401k match.
- The company's insider trading policy prohibits hedging transactions involving its securities by directors, executive officers and all other employees.
Sentiment
Score: 5
Explanation: The document presents a mix of positive and negative aspects. The reverse stock split is a necessary measure to maintain Nasdaq listing, but it carries risks. The capital raise provides funding, but also potential dilution. The cost-cutting measures are prudent but reflect financial challenges.
Positives
- The proposed reverse stock split aims to maintain the company's listing on Nasdaq, which the Board believes is in the best interests of the company and its stockholders.
- The company has taken steps to reduce its monthly cash burn rate, providing more flexibility in anticipation of tougher capital market conditions.
- The Board is committed to responsible corporate governance and periodically reviews and updates its policies and practices.
- The company's insider trading policy expressly prohibits hedging transactions involving its securities by directors, executive officers and all other employees.
Negatives
- A reverse stock split may negatively impact the market for the company's common stock and there is no assurance that the market price will increase proportionally.
- If the company fails to regain compliance with Nasdaq listing requirements, its common stock may be delisted, which could limit stockholders' ability to make transactions in the company's securities.
- Approval of anti-dilution provisions in common warrants could result in significant dilution for existing stockholders if the warrants are exercised.
- The company has recently undertaken steps to reduce our monthly cash burn rate by approximately 40%, balanced against our strategic growth initiatives, which will provide more flexibility in anticipation of tougher capital market conditions for microcap companies like Nuwellis. These reductions include, but are not limited to the following: selected job eliminations, a reduction of the salaries for members of senior management, no merit increases to the base salaries of any named executive officer or employee in 2024 for performance provided during the fiscal year ended December 31, 2023, no cash bonuses to any named executive officer or employee in 2024 for performance provided during the fiscal year ended December 31, 2023, a reduction in Board of Director and committee fees, temporary suspension of company 401k match, travel reductions, and reductions to select professional services.
Risks
- The reverse stock split may not result in a sustained increase in the stock price, and the company may still face delisting from Nasdaq.
- Delisting from Nasdaq could impair the company's ability to raise additional funds and result in lower prices and larger spreads in the bid and ask prices for the company's common stock.
- The issuance of additional shares of common stock upon exercise of warrants may have a dilutive effect on earnings per share and relative voting power.
- The company's future financial results and market conditions may adversely affect the market price of its common stock.
Future Outlook
The Board may implement the reverse stock split to maintain the company's listing on Nasdaq and ensure a sufficient number of authorized shares to satisfy obligations upon the exercise of warrants.
Industry Context
The document does not provide specific details on how this announcement relates to broader industry trends or competitors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Clawback Policy | The Board recently adopted a Clawback Policy, providing that the Company must promptly recover specified incentive-based compensation that is received by our executive officers on or after October 2, 2023, regardless of fault, upon specified accounting restatements of the Company's financial statement that resulted in such persons receiving an amount that exceeded the amount that would have been received if based on the restated financial statements. | N/A | N/A |
Related Party Transactions
- The Company engaged in no related party transactions for the fiscal periods ended December 31, 2023 and 2022.
Stakeholder Impact
- Stockholders may experience dilution if the common warrants are exercised.
- Stockholders may be impacted by the reverse stock split, which could affect the market price and liquidity of the stock.
- Employees may be impacted by the cost-cutting measures, including job eliminations and salary reductions.
- The company's ability to raise capital and finance operations could be affected by the outcome of the proposals.
Next Steps
- Stockholder vote on the proposals at the annual meeting on June 6, 2024.
- Board decision on whether to implement the reverse stock split and at what ratio, if Proposal 2 is approved.
- Company to file the Reverse Stock Split Certificate of Amendment with the Secretary of State of the State of Delaware, if the Board decides to implement the reverse stock split.
- Company to hold a stockholder meeting every sixty days until we obtain the Warrant Stockholder Approval or until the Common Warrants expire, if the Warrant Stockholder Approval is not obtained.
Key Dates
| Date | Description |
|---|---|
| 2011-09-20 | Date on which the Fourth Amended and Restated Certificate of Incorporation was originally filed. |
| 2023-12-07 | Date the company received a letter from Nasdaq regarding non-compliance with the Minimum Bid Price Requirement. |
| 2024-04-08 | Record date for the annual meeting. |
| 2024-04-26 | Date the company entered into a securities purchase agreement with institutional investors. |
| 2024-04-30 | Closing date of the April Offering. |
| 2024-04-30 | Date the notice of annual meeting, proxy statement and form of proxy was first mailed to stockholders of record. |
| 2024-06-04 | Deadline for beneficial owners to register to attend the annual meeting. |
| 2024-06-05 | Deadline to change vote via internet or phone. |
| 2024-06-06 | Date of the 2024 annual meeting of stockholders. |
| 2025-01-10 | Deadline for stockholders to submit proposals for inclusion in the 2025 proxy statement. |
| 2025-02-06 | Earliest date for stockholders to submit director nominations or other business proposals for the 2025 annual meeting. |
| 2025-03-07 | Latest date for stockholders to submit director nominations or other business proposals for the 2025 annual meeting. |
Keywords
reverse stock split, proxy statement, executive compensation, Nasdaq, common warrants, annual meeting, directors, Baker Tilly, anti-dilution, Nuwellis
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.